Notably, for each stage, the serum FAS levels were significantly higher in the cancer patients than in the healthy subjects (stage I, P<0.0001; stage II, P<0.0001; stage III, P<0.0001; and stage IV, P=0.0022). The gene discussed is FAS; the disease is cancer.